BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 21798531)

  • 1. [Cardiovascular disease, osteoporosis and risk of fracture].
    Reyes-García R; Rozas-Moreno P; Muñoz-Torres M
    Rev Clin Esp; 2012 Apr; 212(4):188-92. PubMed ID: 21798531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Declining rates of osteoporosis management following fragility fractures in the U.S., 2000 through 2009.
    Balasubramanian A; Tosi LL; Lane JM; Dirschl DR; Ho PR; O'Malley CD
    J Bone Joint Surg Am; 2014 Apr; 96(7):e52. PubMed ID: 24695929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alendronate decreases the fracture risk in patients with prostate cancer on androgen-deprivation therapy and with severe osteopenia or osteoporosis.
    Planas J; Trilla E; Raventós C; Cecchini L; Orsola A; Salvador C; Placer J; Encabo G; Morote J
    BJU Int; 2009 Dec; 104(11):1637-40. PubMed ID: 19549260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Management of the patient with a high risk of fracture in clinical practice. Results from a survey of 174 Spanish Rheumatologists (OSTEOPAR project)].
    Casado E; Caamaño M; Sánchez-Bursón J; Salas E; Malouf J; Rentero ML; Herrero-Beaumont G
    Reumatol Clin; 2011; 7(5):305-13. PubMed ID: 21925446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diabetes and osteoporosis].
    Ferrari S
    Rev Med Suisse; 2013 Jun; 9(390):1256, 1258-9. PubMed ID: 23821843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skeletal effects of raloxifene after 8 years: results from the continuing outcomes relevant to Evista (CORE) study.
    Siris ES; Harris ST; Eastell R; Zanchetta JR; Goemaere S; Diez-Perez A; Stock JL; Song J; Qu Y; Kulkarni PM; Siddhanti SR; Wong M; Cummings SR;
    J Bone Miner Res; 2005 Sep; 20(9):1514-24. PubMed ID: 16059623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. beta-Blocker use, BMD, and fractures in the study of osteoporotic fractures.
    Reid IR; Gamble GD; Grey AB; Black DM; Ensrud KE; Browner WS; Bauer DC
    J Bone Miner Res; 2005 Apr; 20(4):613-8. PubMed ID: 15765180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.
    Shane E; Silverberg SJ; Donovan D; Papadopoulos A; Staron RB; Addesso V; Jorgesen B; McGregor C; Schulman L
    Am J Med; 1996 Sep; 101(3):262-9. PubMed ID: 8873487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Change in lumbar spine BMD and vertebral fracture risk reduction in teriparatide-treated postmenopausal women with osteoporosis.
    Chen P; Miller PD; Delmas PD; Misurski DA; Krege JH
    J Bone Miner Res; 2006 Nov; 21(11):1785-90. PubMed ID: 17002571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follow-up for osteoporosis in older patients three years after a fracture.
    Schurink M; Hegeman JH; Kreeftenberg HG; Ten Duis HJ
    Neth J Med; 2007 Feb; 65(2):71-4. PubMed ID: 17379932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fracture prevention in Kaiser Permanente Southern California.
    Dell R
    Osteoporos Int; 2011 Aug; 22 Suppl 3():457-60. PubMed ID: 21847765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary prevention of fractures and compliance to treatment in osteoporosis.
    Trevisan C
    Aging Clin Exp Res; 2011 Apr; 23(2 Suppl):22-4. PubMed ID: 21970911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New horizons in fracture risk assessment.
    Aspray TJ
    Age Ageing; 2013 Sep; 42(5):548-54. PubMed ID: 23892830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fighting the fracture cascade: evaluation and management of osteoporotic fractures.
    Sack F
    Postgrad Med; 2008 Nov; 120(4):51-7. PubMed ID: 19020365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strontium ranelate: vertebral and non-vertebral fracture risk reduction.
    Seeman E
    Curr Opin Rheumatol; 2006 Jun; 18 Suppl 1():S17-20. PubMed ID: 16735841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postmenopausal osteoporosis: fracture risk and prevention.
    Kaunitz AM; McClung MR; Feldman RG; Wysocki S
    J Fam Pract; 2009 Nov; 58(11 Suppl Postmenopausal):S1-6. PubMed ID: 19891943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ten-year absolute risk of osteoporotic fractures according to BMD T score at menopause: the Danish Osteoporosis Prevention Study.
    Abrahamsen B; Vestergaard P; Rud B; Bärenholdt O; Jensen JE; Nielsen SP; Mosekilde L; Brixen K
    J Bone Miner Res; 2006 May; 21(5):796-800. PubMed ID: 16734396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventing osteoporotic fractures in older people.
    McCloskey E
    Practitioner; 2011 Jan; 255(1736):19-22, 2-3. PubMed ID: 21370710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between changes in BMD and nonvertebral fracture incidence associated with risedronate: reduction in risk of nonvertebral fracture is not related to change in BMD.
    Watts NB; Geusens P; Barton IP; Felsenberg D
    J Bone Miner Res; 2005 Dec; 20(12):2097-104. PubMed ID: 16294263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bone mineral density in postmenopausal women with proximal femoral fractures--comparative study between quantitative ultrasonometry and gold standard DXA].
    Schnabel M; Eser G; Ziller V; Mann D; Mann E; Hadji P
    Zentralbl Chir; 2005 Oct; 130(5):469-75. PubMed ID: 16220445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.